fetal hemoglobin
2 stories
-
healthCRISPR Cas12a Therapy Boosts Hemoglobin in Sickle Cell Disease
Phase 1-2 data show CRISPR gene editing normalizes hemoglobin and slashes vaso-occlusive events in severe sickle cell disease.
-
healthGene Editing Breakthrough: New Therapy Shows Promise for Beta-Thalassemia
A novel gene editing approach successfully treats beta-thalassemia in a clinical trial, reactivating fetal hemoglobin and eliminating transfusion dependency.